Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广

网站主页 >> 化工产品目录 >> Vosaroxin>> 市场分析报告
 

Vosaroxin市场分析报告

Therapeutic Class Overview: Treating Refractory Hematological Malignancies
Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs ...

Acute Myeloid Leukemia (AML) Therapeutics: Market Research Report
This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the ...

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review
... TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types ...

Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
... . The company's major products include Vosaroxin, TAK-580, SSN-510 and ...




Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系